Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19887475 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED)
Conditions: Advanced Cancer Relapsed;   Advanced Cancer Refractory
Interventions: Drug: vorinostat;   Drug: Comparator: placebo (unspecified)

Indicates status has not been verified in more than two years